Efficient generation of human natural killer cell lines by viral transformation

Leukemia

Volumn 28, Issue 1, 2014, Pages 192-195

  Vogel, B ^a   Tennert, K ^a   Full, F ^a   Ensser, A ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 2; VIRUS DNA;

APOPTOSIS; CELL SURFACE; CELL SURVIVAL; CYTOTOXICITY; EPSTEIN BARR VIRUS; HERPES VIRUS SAIMIRI; HUMAN; LETTER; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; VIRUS TRANSFORMATION;

CELL TRANSFORMATION, VIRAL; HUMANS; KILLER CELLS, NATURAL;

EID: 84891851984     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.188     Document Type: Letter

References (15)

1. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9: 503-510. (Pubitemid 351560519)
2. Yagita M, Huang CL, Umehara H, Matsuo Y, Tabata R, Miyake M et al. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 2000; 14: 922-930. (Pubitemid 30235072)
3. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994; 8: 652-658. (Pubitemid 24133034)
4. Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T et al. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killerlike cell line (YT cells). J Immunol 1985; 134: 1623-1630. (Pubitemid 15130281)
5. Kornbluth J, Flomenberg N, Dupont B. Cell surface phenotype of a cloned line of human natural killer cells. J Immunol 1982; 129: 2831-2837. (Pubitemid 13245567)
6. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996; 24: 406-415. (Pubitemid 26098857)
7. Uphoff CC, Denkmann SA, Steube KG, Drexler HG. Detection of EBV, HBV, HCV, HIV-1, HTLV-I and-II, and SMRV in human and other primate cell lines. J Biomed Biotechnol 2010; 2010: 904767.
8. Biesinger B, Mueller-Fleckenstein I, Simmer B, Lang G, Wittmann S, Platzer E et al. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci USA 1992; 89: 3116-3119.
9. Heck E, Friedrich U, Gack MU, Lengenfelder D, Schmidt M, Mueller-Fleckenstein I et al. Growth transformation of human T cells by herpesvirus saimiri requires multiple Tip-Lck interaction motifs. J Virol 2006; 80: 9934-9942. (Pubitemid 44522587)
10. Stephan V, Wahn V, Le DF, Dirksen U, Broker B, Mueller-Fleckenstein I et al. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N Engl J Med 1996; 335: 1563-1567. (Pubitemid 26384751)
11. Pacheco-Castro A, Al varez-Zapata D, Serrano-Torres P, Regueiro JR. Signaling through a CD3 gamma-deficient TCR/CD3 complex in immortalized mature CD4\+ and CD8\+ T lymphocytes. J Immunol 1998; 161: 3152-3160. (Pubitemid 28425744)
12. Crequer A, Troeger A, Patin E, Ma CS, Picard C, Pedergnana V et al. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest 2012; 122: 3239-3247.
13. Zielke K, Full F, Teufert N, Schmidt M, Mueller-Fleckenstein I, Alberter B et al. The insulator protein CTCF binding sites in the orf73/LANA promoter region of herpesvirus saimiri are involved in conferring episomal stability in latently infected human T cells. J Virol 2012; 86: 1862-1873.
14. Toptan T, Ensser A, Fickenscher H. Rhadinovirus vector-derived human telomerase reverse transcriptase expression in primary T cells. Gene Ther 2010; 17: 653-661.
15. Knappe A, Feldmann G, Dittmer U, Meinl E, Nisslein T, Wittmann S et al. Herpesvirus saimiri-transformed macaque T cells are tolerated and do not cause lymphoma after autologous reinfusion. Blood 2000; 95: 3256-3261. (Pubitemid 30321182)